Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study

Yi-Jen Chen; Yi‐Jen Chen; Teh-Fu Hsu; Teh‐Fu Hsu; Ben-Shian Huang; Hsiao-Wen Tsai; Hsiao‐Wen Tsai; Yen-Hou Chang; Peng‐Hui Wang; Peng-Hui Wang

doi:10.1016/j.ajog.2017.02.008

Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study

Yi-Jen Chen, Yi‐Jen Chen, Teh-Fu Hsu, Teh‐Fu Hsu, Ben-Shian Huang, Hsiao-Wen Tsai, Hsiao‐Wen Tsai, Yen-Hou Chang, Peng‐Hui Wang, Peng-Hui Wang

American journal of obstetrics and gynecology · 2017 · vol. 216(6) , pp. 582.e1–582.e9 · doi:10.1016/j.ajog.2017.02.008 · PMID:28209488 · W2588981441

article OA: bronze CC0 ⤵ 52 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This randomized controlled study investigated the effect of postoperative levonorgestrel-releasing intrauterine system use on endometrioma recurrence in patients undergoing surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosischronic_pelvic_painendometrioma

MeSH descriptors

Endometriosis Intrauterine Devices, Medicated Levonorgestrel Neoplasm Recurrence, Local Adult CA-125 Antigen CA-125 Antigen Contraceptives, Oral, Synthetic Dysmenorrhea Dysmenorrhea Dysmenorrhea Endometriosis Endometriosis Endometriosis Female Humans Levonorgestrel Membrane Proteins Membrane Proteins Neoplasm Recurrence, Local

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Cited by (50)

Source provenance

europepmc: last seen: 2026-06-22T06:15:23.361955+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:20:37.704673+00:00

License: CC0 · commercial use OK

[1] CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis. via openalex

[2] Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex

[3] Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis via openalex

[4] Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex

[5] Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery via openalex

[6] Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial via openalex

[7] Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part I: Clinical results via openalex

[8] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[9] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[10] Patterns of and Risk Factors for Recurrence in Women With Ovarian Endometriomas via openalex

[11] Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence via openalex

[12] Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex

[13] Postoperative levonorgestrel‐releasing intrauterine system versus oral contraceptives after gonadotropin‐releasing hormone agonist treatment for preventing endometrioma recurrence via openalex

[14] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[15] Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex

[16] Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex

[17] Recurrence of ovarian endometrioma after second-line, conservative, laparoscopic cyst enucleation via openalex

[18] Staging of Pelvic Endometriosis: Role of Sonographic Appearance in Determining Extension of Disease and Modulating Surgical Approach via openalex

[19] The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex

[20] The influence of prior oral contraceptive use on risk of endometriosis is conditional on parity via openalex

[21] The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex

[22] The Recurrence of Endometriosis via openalex

[23] The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis via openalex

[24] Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation via openalex

[25] W6600720097 via openalex

[26] W1998757029 via openalex

[27] W2039466335 via openalex

[28] W2048097238 via openalex

[29] W2053998452 via openalex

[30] W2076992081 via openalex

[31] W2131027406 via openalex

[32] W2163863461 via openalex

[33] W2200906614 via openalex